These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29868450)

  • 21. Subcortical matter in the α-synucleinopathies spectrum: an MRI pilot study.
    Gazzina S; Premi E; Turrone R; Acosta-Cabronero J; Rizzetti MC; Cotelli MS; Gasparotti R; Padovani A; Borroni B
    J Neurol; 2016 Aug; 263(8):1575-82. PubMed ID: 27230856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathological roles of α-synuclein in neurological disorders.
    Vekrellis K; Xilouri M; Emmanouilidou E; Rideout HJ; Stefanis L
    Lancet Neurol; 2011 Nov; 10(11):1015-25. PubMed ID: 22014436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease.
    Williams GP; Schonhoff AM; Jurkuvenaite A; Thome AD; Standaert DG; Harms AS
    J Neuroinflammation; 2018 Aug; 15(1):244. PubMed ID: 30165873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High Throughput Sequencing Identifies MicroRNAs Mediating α-Synuclein Toxicity by Targeting Neuroactive-Ligand Receptor Interaction Pathway in Early Stage of Drosophila Parkinson's Disease Model.
    Kong Y; Liang X; Liu L; Zhang D; Wan C; Gan Z; Yuan L
    PLoS One; 2015; 10(9):e0137432. PubMed ID: 26361355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dermal and cardiac autonomic fiber involvement in Parkinson's disease and multiple system atrophy.
    Brumberg J; Kuzkina A; Lapa C; Mammadova S; Buck A; Volkmann J; Sommer C; Isaias IU; Doppler K
    Neurobiol Dis; 2021 Jun; 153():105332. PubMed ID: 33722614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease.
    Tatenhorst L; Eckermann K; Dambeck V; Fonseca-Ornelas L; Walle H; Lopes da Fonseca T; Koch JC; Becker S; Tönges L; Bähr M; Outeiro TF; Zweckstetter M; Lingor P
    Acta Neuropathol Commun; 2016 Apr; 4():39. PubMed ID: 27101974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentially targeted seeding reveals unique pathological alpha-synuclein propagation patterns.
    Rahayel S; Mišić B; Zheng YQ; Liu ZQ; Abdelgawad A; Abbasi N; Caputo A; Zhang B; Lo A; Kehm V; Kozak M; Yoo HS; Dagher A; Luk KC
    Brain; 2022 Jun; 145(5):1743-1756. PubMed ID: 34910119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
    Messina D; Cerasa A; Condino F; Arabia G; Novellino F; Nicoletti G; Salsone M; Morelli M; Lanza PL; Quattrone A
    Parkinsonism Relat Disord; 2011 Mar; 17(3):172-6. PubMed ID: 21236720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Faster disease progression in Parkinson's disease with type 2 diabetes is not associated with increased α-synuclein, tau, amyloid-β or vascular pathology.
    de Pablo-Fernández E; Courtney R; Rockliffe A; Gentleman S; Holton JL; Warner TT
    Neuropathol Appl Neurobiol; 2021 Dec; 47(7):1080-1091. PubMed ID: 33969516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parkinson patient fibroblasts show increased alpha-synuclein expression.
    Hoepken HH; Gispert S; Azizov M; Klinkenberg M; Ricciardi F; Kurz A; Morales-Gordo B; Bonin M; Riess O; Gasser T; Kögel D; Steinmetz H; Auburger G
    Exp Neurol; 2008 Aug; 212(2):307-13. PubMed ID: 18511044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FBXO7 immunoreactivity in α-synuclein-containing inclusions in Parkinson disease and multiple system atrophy.
    Zhao T; Severijnen LA; van der Weiden M; Zheng PP; Oostra BA; Hukema RK; Willemsen R; Kros JM; Bonifati V
    J Neuropathol Exp Neurol; 2013 Jun; 72(6):482-8. PubMed ID: 23656991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. α-Synuclein pathology in Parkinson's disease and related α-synucleinopathies.
    Henderson MX; Trojanowski JQ; Lee VM
    Neurosci Lett; 2019 Sep; 709():134316. PubMed ID: 31170426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson's disease patients.
    Doorn KJ; Moors T; Drukarch B; van de Berg WDj; Lucassen PJ; van Dam AM
    Acta Neuropathol Commun; 2014 Aug; 2():90. PubMed ID: 25099483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morphometric similarity differences in drug-naive Parkinson's disease correlate with transcriptomic signatures.
    Wang Y; Xiao Y; Xing Y; Yu M; Wang X; Ren J; Liu W; Zhong Y
    CNS Neurosci Ther; 2024 Mar; 30(3):e14680. PubMed ID: 38529533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decrease in
    Han S; Seo MH; Lim S; Yeo S
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. From α-synuclein to synaptic dysfunctions: new insights into the pathophysiology of Parkinson's disease.
    Bellucci A; Zaltieri M; Navarria L; Grigoletto J; Missale C; Spano P
    Brain Res; 2012 Oct; 1476():183-202. PubMed ID: 22560500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct α-synuclein promoter transactivation by the tumor suppressor p53.
    Duplan E; Giordano C; Checler F; Alves da Costa C
    Mol Neurodegener; 2016 Feb; 11():13. PubMed ID: 26833254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relation between α-synuclein and microglia in Parkinson's disease: Recent developments.
    Sanchez-Guajardo V; Tentillier N; Romero-Ramos M
    Neuroscience; 2015 Aug; 302():47-58. PubMed ID: 25684748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synuclein impairs trafficking and signaling of BDNF in a mouse model of Parkinson's disease.
    Fang F; Yang W; Florio JB; Rockenstein E; Spencer B; Orain XM; Dong SX; Li H; Chen X; Sung K; Rissman RA; Masliah E; Ding J; Wu C
    Sci Rep; 2017 Jun; 7(1):3868. PubMed ID: 28634349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of LAG3 genetic variation with an increased risk of PD in Chinese female population.
    Guo W; Zhou M; Qiu J; Lin Y; Chen X; Huang S; Mo M; Liu H; Peng G; Zhu X; Xu P
    J Neuroinflammation; 2019 Dec; 16(1):270. PubMed ID: 31847878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.